Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

29,776 signal articles · 63 in last 24h · 148,360 total before filter · latest 20m ago
63last 24h
976last 7d
109● bullish (7d)
124● bearish (7d)
212publishers
AllMacro370Earnings115M&A99Regulatory8Product11Analyst10
✕ clear all filtersticker: ELsentiment: bullishSentiment:bullishneutralbearishshow all (incl. clickbait)
Moderna Surges on Cancer Vaccine; Estee Lauder Rallies on Earnings | Stock Movers
Bloomberg31d agobullishVIDEO
Moderna Surges on Cancer Vaccine; Estee Lauder Rallies on Earnings | Stock Movers

On this episode of Stock Movers: - Shares of Moderna (MRNA) surged by a record 101% - the stock's biggest intraday gain on record - after the biotech said a personalized cancer vaccine combined with partner Merck & Co.'s Keytruda helped cut the recurrence of melanoma in a large, late-stage trial. The study also met a key secondary goal of showing the shot could help prevent tumors from spreading to new areas of the body, the companies said in a statement Wednesday. - Shares of Estee Lauder (EL) rallied after the beauty company's adjusted earnings per share and sales metrics topped consensus expectations for the fourth quarter. The midpoint of fiscal 2027 organic sales and adjusted EPS guidance ranges are above Street views. - Shares of La-Z-Boy (LZB) tumbled at the open after the furniture maker's forecast sales for the second quarter missed the average analyst estimate.

Estée Lauder shares surge on earnings beat, raised margin guidance
Proactive31d agobullish
Estée Lauder shares surge on earnings beat, raised margin guidance

Estee Lauder Companies Inc (NYSE:EL, XETRA:ELAA) shares jumped more than 15% on Wednesday after the beauty group posted fourth-quarter results that beat Wall Street estimates and raised its profit margin outlook for fiscal 2027. The company reported revenue of $3.6 billion for its fiscal...

Estée Lauder Stock Surges as Earnings Show Growth Plan Is Working
Barrons.com31d agobullish
Estée Lauder Stock Surges as Earnings Show Growth Plan Is Working

Shares of Estée Lauder advanced on Wednesday as the beauty and cosmetics giant’s better-than-expected quarterly earnings showed Wall Street its growth plan is well underway. The company announced adjusted earnings of 39 cents a share in the fiscal fourth quarter, up from 9 cents a year ago and above Wall Street’s expectation of 32 cents. Estée Lauder reported adjusted earnings of $2.51 a share for the full fiscal year, up from $1.51 last year.